Presentation is loading. Please wait.

Presentation is loading. Please wait.

Normal Weight-Central Obesity Is Associated with the Highest Mortality Risk in Older Adults with Coronary Artery Disease*†  Saurabh Sharma, MD, John A.

Published byMarshall Charles Modified over 6 years ago

Similar presentations

Presentation on theme: "Normal Weight-Central Obesity Is Associated with the Highest Mortality Risk in Older Adults with Coronary Artery Disease*†  Saurabh Sharma, MD, John A."— Presentation transcript:

1 Normal Weight-Central Obesity Is Associated with the Highest Mortality Risk in Older Adults with Coronary Artery Disease*†  Saurabh Sharma, MD, John A. Batsis, MD, Thais Coutinho, MD, Virend K. Somers, MD, Charlotte Kragelund, MD, Alka M. Kanaya, MD, Francisco Lopez-Jimenez, MD, FACC, FAHA  Journal of Clinical Lipidology  Volume 9, Issue 3, Pages (May 2015) DOI: /j.jacl Copyright © Terms and Conditions

2 Figure 1A 5-Year Mortality in Older Adults with Coronary Artery Disease Based on Different Combinations of Body Mass Index and Waist-Hip Ratio. Abbreviations: CAD= coronary artery disease; BMI = body mass index; WHR = waist-hip ratio. Journal of Clinical Lipidology 2015 9, DOI: ( /j.jacl ) Copyright © Terms and Conditions

3 Figure 1B 2-Year Mortality in Older Adults with Coronary Artery Disease Based on Different Combinations of Body Mass Index and Waist-Hip Ratio. Abbreviations: CAD = coronary artery disease; BMI = body mass index; WHR = waist-hip ratio. Journal of Clinical Lipidology 2015 9, DOI: ( /j.jacl ) Copyright © Terms and Conditions

4 Figure 2 5-Year Mortality in Older Adults with CAD Based on Body Mass Index Alone and Sex-specific Tertiles of Waist-Hip Ratio. Abbreviations: CAD= coronary artery disease; BMI = body mass index; WHR = waist-hip ratio. Journal of Clinical Lipidology 2015 9, DOI: ( /j.jacl ) Copyright © Terms and Conditions

Download ppt "Normal Weight-Central Obesity Is Associated with the Highest Mortality Risk in Older Adults with Coronary Artery Disease*†  Saurabh Sharma, MD, John A."

Similar presentations

Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements 

Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements 
Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting 

Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting 
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality  Rishi K. Wadhera,

A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality  Rishi K. Wadhera,
Air Pollution and Chest Disease

Air Pollution and Chest Disease
Lipid abnormalities in foreign-born and US-born patients in a medical group  Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,

Lipid abnormalities in foreign-born and US-born patients in a medical group  Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,
Individual omega-9 monounsaturated fatty acids and mortality—The Ludwigshafen Risk and Cardiovascular Health Study  Graciela E. Delgado, MSc, Bernhard.

Individual omega-9 monounsaturated fatty acids and mortality—The Ludwigshafen Risk and Cardiovascular Health Study  Graciela E. Delgado, MSc, Bernhard.
Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization  Barak Zafrir, MD, Ronen Jaffe, MD, Ronen Rubinshtein, MD, Basheer Karkabi,

Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization  Barak Zafrir, MD, Ronen Jaffe, MD, Ronen Rubinshtein, MD, Basheer Karkabi,
Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels†  Eli.

Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels†  Eli.
Saurabh Sharma, MD, John A. Batsis, MD, Thais Coutinho, MD, Virend K

Saurabh Sharma, MD, John A. Batsis, MD, Thais Coutinho, MD, Virend K
The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data  Steve E. Humphries, PhD, FRCP, Jackie Cooper,

The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data  Steve E. Humphries, PhD, FRCP, Jackie Cooper,
Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index  Suma Vupputuri, PhD, Caroline.

Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index  Suma Vupputuri, PhD, Caroline.
Marjorie Bastien, Paul Poirier, Isabelle Lemieux, Jean-Pierre Després 

Marjorie Bastien, Paul Poirier, Isabelle Lemieux, Jean-Pierre Després 
Effects of a Workplace Multiple Cardiovascular Disease Risks Reduction Program  Jing-Juin Huang, RN, MSN, Huey-Shyan Lin, PhD, Miaofen Yen, PhD, RN, Wai-Ming.

Effects of a Workplace Multiple Cardiovascular Disease Risks Reduction Program  Jing-Juin Huang, RN, MSN, Huey-Shyan Lin, PhD, Miaofen Yen, PhD, RN, Wai-Ming.
Experimental Weight Gain Increases Ambulatory Blood Pressure in Healthy Subjects: Implications of Visceral Fat Accumulation  Naima Covassin, PhD, Fatima.

Experimental Weight Gain Increases Ambulatory Blood Pressure in Healthy Subjects: Implications of Visceral Fat Accumulation  Naima Covassin, PhD, Fatima.
Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.

Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.
An assessment by the Statin Muscle Safety Task Force: 2014 update

An assessment by the Statin Muscle Safety Task Force: 2014 update
An assessment by the Statin Liver Safety Task Force: 2014 update

An assessment by the Statin Liver Safety Task Force: 2014 update
Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled.

Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled.
Evaluation of Kidney Donors: Core Curriculum 2018

Evaluation of Kidney Donors: Core Curriculum 2018
Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia  Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA,

Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia  Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA,

Similar presentations

Ads by Google